VCEL (Vericel) Total Deposits

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VCEL Vericel Corp VCEL
83 GF Score
Price $48.16
GF Value $55.02
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Vericel Total Deposits?

Total Deposits only applies to banks.

VCEL
83GF Score
Vericel Corp VCEL
Total Deposits is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vericel (VCEL) Overvalued in 2026?

Based on GuruFocus' analysis, Vericel stock appears to be undervalued. The current stock price of $48.16 is trading 12.5% below its estimated GF Value™ of $55.02. GuruFocus considers Vericel to be Modestly Undervalued.

Key valuation signals for VCEL:

  • Total Deposits:
  • GF Value™: $55.02 vs. price of $48.16 (12.5% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the VCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vericel Business Description

Other Exchanges ATQP:Germany
Address 64 Sidney Street, Cambridge, MA, USA, 02139
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
83GF Score

Get the complete analysis for VCEL

Total Deposits is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$48.16
Price
$55.02
GF Value